Novel crystalline forms of 1-(4-{ [6-amino-5-(4-phenoxy-phenyl)-pyrimidin-4-ylamino]-methyl} -piperidin-1-yl)-propenone

Novel crystalline forms of 1-(4-{ [6-amino-5-(4-phenoxy-phenyl)-pyrimidin-4-ylamino]-methyl} -piperidin-1-yl)-propenone

The present invention relates to crystalline forms of 1-(4-{ [6-Amino-5-(4-phenoxy-phenyl)-pyrimidin-4-ylamino]-methyl} -piperidin-1-yl)-propenone, a.k.a evobrutinib, useful as BTK inhibitors.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Saal, Christoph, Poma, Marco, Burini, Edoardo, Theuerkorn, Vedad, Becker, Axel
Format: Patent
Sprache:eng
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention relates to crystalline forms of 1-(4-{ [6-Amino-5-(4-phenoxy-phenyl)-pyrimidin-4-ylamino]-methyl} -piperidin-1-yl)-propenone, a.k.a evobrutinib, useful as BTK inhibitors.